Tag Archives: NYSE:JNJ

Johnson & Johnson (JNJ): New Buy Recommendation for This Healthcare Giant

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Johnson & Johnson (NYSE: JNJ). The company’s shares closed yesterday at $136.56. According to TipRanks.com, Selvaraju is ranked 0 out of 5 stars with an

Jefferies Sticks to Its Buy Rating for Johnson & Johnson

In a report issued on July 13, Ian Hilliker from Jefferies maintained a Buy rating on Johnson & Johnson (NYSE: JNJ), with a price target of $145. The company’s shares closed on Friday at $125.93. According to TipRanks.com, Hilliker is

Credit Suisse Upgrades Johnson & Johnson to Buy

In a report issued on April 12, Vamil Divan from Credit Suisse upgraded Johnson & Johnson (NYSE: JNJ) to Buy, with a price target of $154. The company’s shares closed yesterday at $130.62. According to TipRanks.com, Divan is ranked 0

Jefferies Reiterates a Buy Rating on Johnson & Johnson

Jefferies analyst Ian Hilliker reiterated a Buy rating on Johnson & Johnson (NYSE: JNJ) today and set a price target of $161. The company’s shares closed yesterday at $127.38. According to TipRanks.com, Hilliker is a 1-star analyst with an average

The Exec VP, Chief Scientific Off of Johnson & Johnson is Exercising Options

Yesterday, the Exec VP, Chief Scientific Off of Johnson & Johnson, Paulus Stoffels, exercised options of Johnson & Johnson for $20.17M. Following Paulus Stoffels’ last JNJ Sell transaction on July 26, 2017, the stock climbed by 3.8%. Based on Johnson

BTIG Keeps a Sell Rating on Johnson & Johnson

In a report released yesterday, Dane Leone from BTIG reiterated a Sell rating on Johnson & Johnson (NYSE: JNJ), with a price target of $110. The company’s shares closed yesterday at $141.83. Leone wrote: “Present – Starting to Outweigh Macro